Professional Documents
Culture Documents
PBL #3 Pulmonary Tuberculosis Group (A)
PBL #3 Pulmonary Tuberculosis Group (A)
Pulmonary Tuberculosis
Group (A)
Pulmonary
Tuberculosis
By: Ali Hussain Al-Harshan
Table of contents
01 02
Microbial agent
Definition
Overview on Mycobacterium
Tuberculosis
03 04
Types Epidemiology
01
Definition
* What is TB?
Tuberculosis (TB) is ??
TB caused by?
Mode of Transmission??
* Mycobacterium Tuberculosis
02
Epidemiology
* Epidemiology
1- Active TB 2- Latent
* Cilinically: Bacilli go dormant in lungs (Carrier state -
I. Primary without symptoms) i.e., TB test ??
II. Secondary Can Latent TB turn into active or just
continuous as dormant ?
3- Extrapulmonary
During ? bacilli disseminated to ?
(most common) ?
(2nd most common) ?
Mycobacterium Tuberculosis
Mohammed Ali
MORPHOLOGY and Characteristics
Slightly curved rods with rounded ends.
They are non-motile, non-sporing, non-capsulated, and acid-fast bacilli.
Aerobic
CELL WALL
Mycolic acid which are responsible for?
morphology of mycobacteria
13
ANTIGENIC STRUCTURE
• Two types of antigens , cell wall (insoluble) , and cytoplasmic
(soluble) antigens.
• Virulence factors
• Does it have exotoxins?
MODE OF INFECTION
Human become infected with M. tuberculosis by inhalation of
infective droplets coughed or sneezed in to air by a patient with
tuberculosis.
What is the finding?
15
The activity of TB
16
TB favor the apex of lung,
why?
17
Pathogenesis of TB
Abdulaziz Asiri
Transmission
Virulence factors
Fate of T.B.
•Thank you
RECURRENT TB
Presented by: Yasir Awaji
Recurrent tuberculosis: the
diagnosis of a subsequent episode of
TB following cure treatment.
Types:
I. TB Relapse
II. TB Reinfection
A. Relapse: Relapse disease is defined as a subsequent
episode of TB disease due to the reactivation of the original
infecting strain of MTB, determined by genotypic
homogeneity assessment of primary and recurrent MTB
strains.
LABORATORY BIOCHEMICAL
METHODS 01 TESTING 02
- Catalase : negative.
CHEST X-RAY
Cavity Consolidation
Ghon focus
TUBERCULIN TEST
● A skin test to detect development of Cell mediated immunity
and delayed hypersensitivity to Tuberculosis.
● Also called Mantoux test.
● Preparations :
● Purified Protein Derivative (PPD).
● look for red wheal to form in 48-72 hours.
Uses of tuberculin test:
- Diagnose active infection in infants and young children.
- To select susceptibles for BCG vaccines & indication of
successful BCG vaccination.
NUCLEIC ACID AMPLIFICATION TESTING (NAAT)
- A nucleic acid amplification test, or NAAT, for tuberculosis (TB) is
a molecular test used to detect the DNA of Mycobacterium
tuberculosis complex (MTBC) in a sputum or other respiratory
sample.
- Because the amount of DNA in a sample is very small, NAA testing
includes a step that amplifies (or copies) the genetic material.
- Polymerase Chain Reaction (PCR) is a common form of NAAT
used in laboratory diagnosis.
ADVANTAGES OF A NAAT FOR TB?
✓ A NAAT can detect MTBC genetic material even when very small amounts
are present in the sample tested.
✓ NAAT results are typically available in 24 to 48 hours.
Thanks
Any questions?
DDx
Pulmonary tuberculosis
• Bacterial pneumonia
• Brucellosis
• Bronchogenic carcinoma
01 Bacterial pneumonia
Sudden onset of symptoms, such as high
fever, cough, purulent sputum, chest pain,
leukocytosis, chest X-ray shows
consolidation.
02 Bronchogenic carcinoma
may be asymptomatic, usually at
older ages (> 50 years
old) cough, hemoptysis, weight
loss
03 Brucellosis
Fever, anorexia, night sweats,malaise,
back pain , headache, and depression.
History of exposure to infected
animal
Extra-pulmonary tuberculosis
❖ First-line” drugs:
Isoniazid (INH), Rifampin (RIF), Pyrazinamide (PZA), Ethambutol (EMB),
Streptomycin (SM)
❖ Second-line” drugs:
Ethionamid, Capreomycin, Cycloserine, Amino salicylic Acid (PAS), Ciprofloxacin,
Ofloxacin, Rifabutin, Clofazimine
TB Treatment
1- Isoniazid (INH) :
• a. Allergy reactions – fever and skin rashes, lupus
erythematosus
vomiting, jaundice
❑ -Toxicity depends on age, is greater in alcoholic, during
C. Peripheral neuropathy
• Due to INH-induced pyridoxine deficiency .
• More frequent in alcoholic, poor nourished persons, elderly .
• Daily dose of 25 to 50 mg of pyridoxine can prevent this complications
D. Anemia
E. Agranulocytosis
Q1:
• A. isoniazid
• B. rifampin
• C. PAS
• D. streptomycin
Adverse reactions of antituberculosis drugs:
2- Rifampin:
• Hepatitis ( transient increase of transaminase and bilirubin)
• Thrombocytopenia
• Renal failure
• Fever
• Allergic reactions
Adverse reactions of antituberculosis drugs:
3-Pyrazinamide :
• Hepatotoxicity (1-5% patients) especially, when high doses are used.
• Hyperuricemia .
• Gastrointestinal symptoms.
4-Streptomycin :
• Nephrotoxicity – renal tubular damage
• Ototoxicity
• Vestibular damage
Adverse reactions of antituberculosis drugs:
5-Ethambutol (EMB) :
• Can affect ocular nerve (first symptom is inability to distinguish blue from
green) .
• Hyperuricemia.
Therapeutic protocols of T.B.:
• A. INH
• B. Pyrazinamide
• C. Streptomycin
• D. Rifampicin
Complications
Khalid Shaker Althagafi
Complications
Pneumothorax
Systemic amyloidosis